Patient-centered, Optimal Integration of Survivorship and Palliative Care

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this study is to develop and test the feasibility of a supportive care model (POISE) for patients with metastatic Non-small Cell Lung Cancer (NSCLC). The main questions are * is POISE feasible to deliver and acceptable to patients * what is the effect of POISE on the distress patients feel related to their uncertain future, their confidence in their ability to manage cancer, and their understanding about what to expect Participants in the randomized controlled trial will receive either the new supportive care model, POISE, which consists of four visits with a trained palliative care clinician, or care as usual, and will be asked to complete three surveys.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age 18 or older

• MGH Cancer Center patient

• Within 6 months of diagnosis of metastatic NSCLC with oncogenic driver mutation (EGFR, ALK, ROS1, RET)

• Receiving targeted therapy

• Ability to respond in English or Spanish

Locations
United States
Massachusetts
Massachusetts General Hospital
RECRUITING
Boston
Contact Information
Primary
Laura A Petrillo, MD
lpetrillo2@mgh.harvard.edu
(617) 724-4000
Time Frame
Start Date: 2023-09-29
Estimated Completion Date: 2027-09-01
Participants
Target number of participants: 70
Treatments
Experimental: POISE
The intervention will be a structured palliative care intervention in which patients will meet with a palliative care clinician who has been trained on a manual with specific topics to be covered in each of the four visits:~* Three surveys: baseline, 12-week, and 20-week post-enrollment~* Four 60-minute visits with a trained palliative care clinician~* Semi-structured exit interview~* Chart review
No_intervention: Usual care
Patients randomized to usual care will receive usual oncology care. They may access standard palliative care as clinically indicated.
Sponsors
Leads: Massachusetts General Hospital

This content was sourced from clinicaltrials.gov